BE902475A - Tridecapeptides biologiquement actifs. - Google Patents
Tridecapeptides biologiquement actifs.Info
- Publication number
- BE902475A BE902475A BE0/215051A BE215051A BE902475A BE 902475 A BE902475 A BE 902475A BE 0/215051 A BE0/215051 A BE 0/215051A BE 215051 A BE215051 A BE 215051A BE 902475 A BE902475 A BE 902475A
- Authority
- BE
- Belgium
- Prior art keywords
- pro
- alkoxycarbonyl
- alkyl
- aralkoxycarbonyl
- aralkyl
- Prior art date
Links
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 150000007649 L alpha amino acids Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- -1 aralkoxycarbonyl Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848413272A GB8413272D0 (en) | 1984-05-24 | 1984-05-24 | Biologically active tridecapeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE902475A true BE902475A (fr) | 1985-09-16 |
Family
ID=10561441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/215051A BE902475A (fr) | 1984-05-24 | 1985-05-22 | Tridecapeptides biologiquement actifs. |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS6197A (ja) |
| BE (1) | BE902475A (ja) |
| DE (1) | DE3518086A1 (ja) |
| GB (2) | GB8413272D0 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2183643C1 (ru) * | 2000-12-18 | 2002-06-20 | Государственный научно-исследовательский институт особо чистых биопрепаратов | Пептид, обладающий биоцидной активностью |
-
1984
- 1984-05-24 GB GB848413272A patent/GB8413272D0/en active Pending
-
1985
- 1985-05-20 DE DE19853518086 patent/DE3518086A1/de not_active Ceased
- 1985-05-21 JP JP60107084A patent/JPS6197A/ja active Pending
- 1985-05-21 GB GB08512761A patent/GB2156822A/en not_active Withdrawn
- 1985-05-22 BE BE0/215051A patent/BE902475A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6197A (ja) | 1986-01-06 |
| GB8413272D0 (en) | 1984-06-27 |
| GB8512761D0 (en) | 1985-06-26 |
| GB2156822A (en) | 1985-10-16 |
| DE3518086A1 (de) | 1985-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN94035A1 (fr) | Composition veterinaire | |
| FR2571967B1 (fr) | Composition pharmaceutique et procede de traitement du corps. | |
| Brunda et al. | Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases | |
| MX163955B (es) | Composicion farmaceutica de dihidrocodeina e ibuprofen | |
| PT76502A (en) | Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences | |
| DE3650358D1 (de) | Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis. | |
| ATE123381T1 (de) | Verabreichung von wirkstoffen zu wassertieren mittels überschallen. | |
| ATE87485T1 (de) | Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen. | |
| PT78275B (fr) | Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant | |
| BE902475A (fr) | Tridecapeptides biologiquement actifs. | |
| FR2529081B1 (fr) | Composition therapeutique a base d'acide 5-hydroxydecanoique ou d'un de ses derives pour le traitement des maladies cardiovasculaires | |
| ATE40793T1 (de) | Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen. | |
| FR2556593B1 (fr) | Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels | |
| ATE114471T1 (de) | Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse. | |
| DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| FR2601030B1 (fr) | Compositions acides a hautes concentrations en matieres actives pour le traitement des eaux et/ou le nettoyage des installations les contenant | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| FR2412313A1 (fr) | Composition pharmaceutique a base de mono-saccharide et d'amino-acide administrable par voie orale a des etres humains | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| DK0741579T3 (da) | Vandig formulering med forhalet frigivelse | |
| Cohen et al. | Enhancement of adrenocorticotrophic activity | |
| BE905706A (fr) | Melanges herbicides et leur utilisation pour le traitement des cultures. | |
| FR2649864B1 (fr) | Procede de traitement de foie gras ou autres pieces de chair animale destinees a la consommation | |
| JPS53104714A (en) | Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation | |
| RO94153A2 (ro) | Medicament curativ pentru tratarea plagilor cu larve la toate speciile de animale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A. Effective date: 19900531 |